Ann: Appendix 4C - quarterly, page-10

They commence invoicing Strides on a monthly basis imo from January 2019 onward. So unless they disclose through further announcements the amount per month invoiced we will have to await the next quarterly to figure it out.

However, not too difficult.

At present during January they received $100k from Zelda Therapeutics Ltd and are awaiting $100K from Mitsubishi Tanabe Pharma Singapore Pte Ltd. Add to that any other upfront payments announced etc this should provide a basis for estimating the monthly Strides invoicing amount.